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Polycomb group (PcG) proteins are essential regula-
tors of stem cells. PcG and trithorax group proteins
mark developmental regulator gene promoters with
bivalent domains consisting of overlapping repres-
sive and activating histone modifications to keep
them poised for activation in embryonic stem cells.
Bmi1, a component of PcG complexes, maintains
the self-renewal capacity of adult stem cells, but its
role in multipotency remains obscure. Here we
show that Bmi1 is critical formultipotency of hemato-
poietic stem cells (HSCs) and multipotent progeni-
tors (MPPs). B cell lineage developmental regulator
genes, Ebf1 and Pax5, appeared to be transcription-
ally repressed by bivalent domains before lineage
commitment. Loss of Bmi1 resulted in a resolution
of bivalent domains at the Ebf1 andPax5 loci, leading
to their premature expression in HSC/MPPs accom-
panied by accelerated lymphoid specification and
a marked reduction in HSC/MPPs. Thus, Bmi1 is
required to reinforce bivalent domains at key devel-
opmental regulator gene loci to maintain lineage
specification poised for activation in adult stem cells.
INTRODUCTION
All hematopoietic cells are generated from hematopoietic stem
cells (HSCs) via a hierarchy of progenitor populations with
restricted differentiation potential. Although many transcription
factors that play key roles in the lineage commitment of HSCs
have been identified, the precise regulation of their expression
in HSCs remains to be elucidated (Dias et al., 2008; Laslo
et al., 2008; Orkin and Zon, 2008). Polycomb group (PcG)
proteins are involved in the maintenance of gene silencing
through chromatin modifications and have been implicated in
stem cell self-renewal (Sparmann and van Lohuizen, 2006;Pietersen and van Lohuizen, 2008). They reside in two main
complexes, termed Polycomb repressive complex 1 and 2
(PRC1 and PRC2). PRC2 and trithorax group (trxG) proteins
mark developmental regulator gene promoters with bivalent
domains consisting of overlapping repressive and activating
histone modifications to keep developmental regulators
‘‘poised’’ for activation in embryonic stem cells (ESCs) (Bernstein
et al., 2006; Spivakov and Fisher 2007; Mendenhall and Bern-
stein, 2008). Likewise, in adult stem cells, developmental regula-
tors that govern lineage specification are supposedly repressed
epigenetically to maintain their multipotency (Pietersen and van
Lohuizen, 2008). Among PcG proteins, Bmi1, a component of
PRC1, and its role in the inheritance of the stemness of adult
stem cells have been well characterized (Molofsky et al., 2003;
Park et al., 2003; Iwama et al., 2004). Bmi1 maintains the self-
renewal capacity of adult stem cells, at least partially, by repres-
sing the Ink4a/Arf locus, which encodes a cyclin-dependent
kinase inhibitor, p16Ink4a, and a tumor suppressor, p19Arf
(Jacobs et al., 1999; Oguro et al., 2006). Deletion of both Ink4a
and Arf in Bmi1-deficient mice substantially restored the defec-
tive self-renewal capacity of HSCs (Oguro et al., 2006) and neural
stem cells. On the other hand, comprehensive genome-wide
analyses demonstrated that PcGproteins directly repress a large
cohort of developmental regulators in ESCs and, by doing so,
maintain ESCs in an undifferentiated pluripotent state (Boyer
et al., 2006; Lee et al., 2006). In adult stem cells, however, target
genes for Bmi1 involved in stem cell functions other than Ink4a/
Arf have not beenwell documented, and the contribution of Bmi1
to the multipotency and lineage specification of stem cells
remains unclear. Here we show that Bmi1 plays a crucial role
in preventing premature lineage specification of HSCs andmulti-
potent progenitors (MPPs) through reinforcement of bivalent
domains at key developmental gene loci.
RESULTS
Premature Derepression of B Cell Lineage-Regulator
Genes in Bmi1-Deficient Multipotent Progenitors
Target genes for Bmi1 involved in stem cell functions other than
Ink4a/Arf have not been well documented. To address this issue,Cell Stem Cell 6, 279–286, March 5, 2010 ª2010 Elsevier Inc. 279
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Figure 1. Premature Derepression of B
Lineage Regulator Genes in Bmi1/Ink4a-
Arf/ HSCs/MPPs
(A) Heat map of the expression of B lineage-
associated genes in a microarray analysis of
IL-7RaKSLHSCs/MPPs. Red, higher expression;
green, lower expression than wild-type average.
(B) Semiquantitative RT-PCR analysis of B lineage
developmental genes,Bmi1, Ink4a, and Arf in wild-
type, Ink4a-Arf/, Bmi1/, and Bmi1/Ink4a-
Arf/ IL-7RaKSL cells.
(C and D) Quantitative RT-PCR analysis of Ebf1 (C)
and Pax5 (D). mRNA levels in indicated progenitor
fractions purified from recipient mouse BM repo-
pulated by wild-type, Ink4a-Arf/, and Bmi1/
Ink4a-Arf/ BM cells were normalized to Hprt1
expression. Expression levels relative to those
in the wild-type pro-B cells are shown as the
mean ± standard deviation (SD) for triplicate
analyses. **p < 0.01. See also Figure S1.
Cell Stem Cell
Bmi1 Inhibits Premature Differentiation of HSCswe compared gene expression profiles of HSC/MPP cells in IL-
7Rac-Kit+Sca-1+Lineage (IL-7RaKSL) fractions from bone
marrow (BM) of wild-type, Ink4a-Arf/, Bmi1/, and Bmi1/
Ink4a-Arf/ mice. Unexpectedly, a set of genes specific to the
B lymphoid lineage, but not T lymphoid or myeloid lineage,
were prematurely derepressed in both Bmi1/ and Bmi1/
Ink4a-Arf/ HSC/MPPs (Figure 1A; Figures S1A and S1B avail-
able online). Among these genes, Ebf1 and Pax5 are B cell-
specific master transcription factor genes that function in B
lineage specification at the earliest stage of B cell differentiation,
and other genes are their downstream targets (Dias et al., 2008;
Laslo et al., 2008). Semiquantitative RT-PCR confirmed that
Ebf1, Pax5, and downstream targets were derepressed in
Bmi1/ and Bmi1/Ink4a-Arf/ IL-7RaKSL cells, while the
expression of upstream genes, Sfpi1 (PU.1), Tcfe2a (E2a), and
Il7r, was not altered (Figure 1B). We next quantified the Ebf1
and Pax5 expression in each progenitor fraction by quantitative
RT-PCR. Because the BM environment of Bmi1/ and Bmi1/
Ink4a-Arf/mice is unable to support HSCs (Oguro et al., 2006),
we purified progenitors from wild-type recipient BM reconsti-
tuted with Bmi1/Ink4a-Arf/ BM cells to exclude the environ-
mental effect. Ebf1 and Pax5 were derepressed in Flt3IL-
7RaKSL HSC/MPPs and Flt3+IL-7RaKSL lymphoid-primed
multipotent progenitors (LMPPs), and even in myeloid
committed progenitors including common myeloid progenitors
(CMPs) and megakaryocyte/erythroid progenitors (MEPs),
although the expression levels were considerably low compared280 Cell Stem Cell 6, 279–286, March 5, 2010 ª2010 Elsevier Inc.to those in wild-type pre-B cells (Figures
1C and 1D). To confirm these findings at
a single-cell level, we compared the dere-
pressed Pax5 protein levels by immunos-
taning with an ArrayScan, a cell image
analyzer designed for high-capacity
automated fluorescence imaging and
quantitative analysis. Two hundred cells
were scanned and the fluorescence
intensity was plotted in Figure S1C. Dere-
pression of Pax5 protein was evident in
HSC/MPPs and LMPPs compared tolevels of Pax5 in wild-type cells. Common lymphoid progenitors
(CLPs) that possess both B and T lymphoid potential also ex-
pressed significantly higher levels of Ebf1 and Pax5 in the
absence of Bmi1, whereas Ebf1 and Pax5 were strictly silenced
in T cell lineage progenitors. These results suggest that Bmi1
functions in the silencing of Ebf1 and Pax5 in HSC/MPP/LMPPs
and myeloid progenitors and that Ink4a and Arf are not involved
in the transcriptional regulation of these genes.
Direct Repression of Ebf1 and Pax5 Expression
by Bmi1 through Repressive Histone Modifications
at Their Promoters
To confirm this, we characterized the Ebf1 and Pax5 promoters
by conducting chromatin immunoprecipitation (ChIP) assays. To
obtain enough cells, we used BM lineage marker-negative (Lin-
eage) progenitors depleted of cells committed to the lymphoid,
myeloid, and erythroid lineages. Binding of Bmi1 to both of the
Ebf1 promoters (Roessler et al., 2007) and to the Pax5 promoter
was detected, but not to the promoter of Il7r, a gene upstream of
Ebf1 (Figures 2A and 2B). Bivalent domains in ESCs consist of
a repressive mark, trimethylation of histone H3 at lysine 27
(H3K27me3) catalyzed by PRC2, and an active mark, trimethyla-
tion of histone H3 at lysine 4 (H3K4me3) catalyzed by trxG
proteins. PRC1 catalyzes the monoubiquitination of histone
H2A (H2Aub1) at lysine 119 and thereby impedes RNA poly-
merase II elongation. Bivalent domains that carry both PRC2
and PRC1 are efficiently retained upon the differentiation of
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Figure 2. Recruitment of Bmi1 and Histone
Modification Status at the Ebf1 and Pax5
Promoter Loci
(A) Diagram illustrating the genomic context of
Ebf1 and Pax5 promoter loci. Regions amplified
by site-specific quantitative PCR are indicated by
bars.
(B and C) ChIP analyses of wild-type (gray bar) or
Bmi1/Ink4a-Arf/ (green bar) Lineage cells in
Ebf1 and Pax5 promoter regions and Il7r and
Actb control promoter regions via anti-Bmi1 (B)
or anti-H2Aub1 antibody (C). Percentages of input
DNA are shown as the mean ± SD for triplicate
analyses. *p < 0.05, **p < 0.01.
(D and E) ChIP analyses of wild-type (gray bar) or
Bmi1/Ink4a-Arf/ (green bar) Lineage cells
and wild-type (faint yellow bar) or Bmi1/Ink4a-
Arf/ (yellow bar) IgMB220+ B cells via anti-
H3K4me3 (D) or anti-H3K27me3 (E) antibody.
Percentages of input DNA are shown as the
mean ± SD for triplicate analyses. *p < 0.05;
**p < 0.01. See also Figure S2.
Cell Stem Cell
Bmi1 Inhibits Premature Differentiation of HSCsESCs into somatic stem/progenitor cells and account for the vast
majority of developmental regulator gene promoters (Ku et al.,
2008). The Ebf1 and Pax5 promoters carried both H3K27me3
and H3K4me3 along with H2Aub1 (bivalent state) in wild-type
BM Lineage progenitors, but lost H3K27me3 in wild-type B
cells (active monovalent state) (Figures 2C–2E). Of note, they
lost, at least partially but to a significant extent, not only
H2Aub1 but also H3K27me3 in Bmi1/Ink4a-Arf/ Lineage
progenitors compared with levels in wild-type cells, whereas
H3K4me3 levels were left unchanged. These results indicate
that Bmi1 directly represses the expression of both Ebf1 and
Pax5 by keeping their promoters in a bivalent state and suggest
that PRC1 affects PRC2 function or stabilizes the H3K27me3
modification (Figure S2).
BM Environment Unable to Support B Lymphopoiesis
in Bmi1-Deficient Mice
Based on these findings, we next investigated the impact of
derepression of Ebf1 and Pax5 in HSC/MPP/LMPPs. Overex-
pression of Ebf1 and Pax5 in hematopoietic progenitors is
reportedly sufficient to skew the developmental potential of
lymphoid progenitors toward the B cell lineage at the expense
of T lymphopoiesis (Souabni et al., 2002; Zhang et al., 2003; Pon-
gubala et al., 2008). In contrast, loss of each PRC1 component in
mice commonly caused arrested lymphoid development at pre-
B and CD4CD8 double-negative (DN) stages (van der Lugt,
et al., 1994; Raaphorst et al., 2001). Deletion of both Ink4a and
Arf or Arf only in Bmi1/ mice partially restored splenocyte
and thymocyte numbers (Jacobs et al., 1999) and largely
released a differentiation block in thymic T cells (Miyazaki
et al., 2008). However, deletion of Ink4a/Arf did not release theCell Stem Cell 6, 279–286, March 5, 2010 ª2010 Elsevier Inc. 281t
tdifferentiation block at the pre-B stage in
Bmi1/ BM, and restored their numbers
only partially (Figure 3A). As described
above, the Bmi1/ BM environment is
unable to support HSC self-renewal and
this appeared to be true for B cell devel-opment in Bmi1/ mice. Wild-type BM cells were transplanted
into sublethally irradiated Bmi1/ recipient mice, and as ex-
pected, B cell differentiation was significantly compromised a
the pre-B cell stage in the Bmi1/ BM environmen
(Figure S3A). A similar differentiation block was also reported
in B cells deficient in PRC2 genes, Ezh2 and Yy1, and has
been attributed to defective somatic rearrangements of the
immunoglobulin heavy chain gene (Igh) (Su et al., 2003; Liu
et al., 2007). However, this was not the case in Bmi1/ B cells
(Figure S3B).
Enhanced B Lymphopoiesis at the Expense of
T Lymphopoiesis in Bmi1/Ink4a-Arf/ BM Cells
To evaluate the real impact of loss of Bmi1 on lymphocyte differ-
entiation, we transplanted Bmi1/Ink4a-Arf/ BM cells into
wild-type recipient mice and analyzed their differentiation in
a normal BM environment. In wild-type recipients, the develop-
mental arrest of Bmi1/Ink4a-Arf/ cells at the pre-B stage
was completely released, and, as expected from the dere-
pressed expression of Ebf1 and Pax5, Bmi1/Ink4a-Arf/
hematopoietic cells generated 4-fold more CLPs and increased
numbers of B lineage progenitors (Figure 3B). These results
confirmed that an environment unable to support B lymphopoi-
esis largely accounts for the impaired lymphopoiesis in Bmi1/
Ink4a-Arf/mice and demonstrated that lymphoid specification
and subsequent B lymphopoiesis is unexpectedly enhanced by
loss ofBmi1. In contrast, thymic reconstitution byBmi1/Ink4a-
Arf/ BM cells was severely compromised to one-tenth
(Figure 3C). Numbers of thymic progenitors were significantly
decreased in the earliest progenitor fraction, early thymic
progenitors (ETPs), but the reduction in T cells at the later stages
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Figure 3. Bmi1/Ink4a-Arf/ BM Cells
Show Enhanced B Lymphopoiesis at the
Expense of T Lymphopoiesis and Reduced
HSC/MPP Numbers in a Normal Environ-
ment
(A) Numbers of BM B lineage progenitors and
splenic B cells per body weight of 4-week-old
mice. Data were normalized relative to the wild-
type and are shown as the mean ± SD (5% n% 7).
(B) Numbers of donor-derived BM B cell lineage
progenitors and splenic B cells recovered from
the wild-type recipient mice repopulated by BM
cells of indicated mutant mice. Data were normal-
ized relative to the wild-type and are shown as the
mean ± SD (5% n% 9).
(C) Cell counts of BM, spleen, thymus, and periph-
eral blood (PB) of wild-type recipient mice repopu-
lated by BM cells of indicated mutant mice. Data
were normalized relative to the wild-type and are
shown as the mean ± SD (8% n% 20).
(D) Numbers of donor-derived thymic T cell lineage
progenitor cells and B220+ B cells recovered from
the wild-type recipient mice repopulated by BM
cells of indicated mutant mice. Data were normal-
ized relative to the wild-type and are shown as the
mean ± SD (4% n% 7).
(E) Thymic reconstitution potential of LMPPs on
intrathymic and intravenous injection. Thymic
reconstitution potential was evaluated by intrathy-
mic and intraveneous injections of LMPPs recov-
ered from the wild-type recipient mice repopu-
lated by BM cells of indicated mutant mice. 250
freshly isolated donor LMPPs (B6-Ly5.2) were
mixed with the same number of competitor wild-
type LMPPs (B6-Ly5.1/Ly5.2 F1) and injected
into each thymic lobe of recipient B6-Ly5.1 mice
irradiated with a dose of 6.0Gy. 1000 freshly iso-
lated donor LMPPs (B6-Ly5.2) were mixed with
the same number of competitor wild-type LMPPs
(B6-Ly5.1/Ly5.2 F1) and intravenously injected
into recipient B6-Ly5.1 mice irradiated with a
dose of 6.0Gy. Each dot shows the percent chimerism of donor cells in the recipient thymic DP fraction analyzed at 20 days after transplantation. Bars
indicate the mean (intrathymic injection, WT; n = 6, others; n = 10, intravenous injection, n = 10). See also Figure S3.
Cell Stem Cell
Bmi1 Inhibits Premature Differentiation of HSCswas relatively moderate (Figure 3D). Of importance, Bmi1/
Ink4a-Arf/ LMPPs did not show any defects in migration/
homing to and expansion in the thymus in experiments with intra-
thymic and intravenous injections (Figure 3E). Furthermore, the
growth and differentiation of most immature thymic progenitors,
ETPs and DN2 cells, frommice reconstituted withBmi1/Ink4a-
Arf/ BM cells, were not compromised in culture (Figure S3C).
Thus, the impaired thymic reconstitution was assumed to be
due to the reduced production of T cell progenitors in BM that
subsequently migrate and home to the thymus. Of interest,
HSCs, MPPs, and LMPPswere considerably decreased in abso-
lute numbers (Figure 3B), further supporting enhanced prema-
ture differentiation of Bmi1/Ink4a-Arf/ multipotent stem/
progenitor cells induced by derepressed expression of Ebf1
and Pax5.
To confirm the direct effect of derepressed Ebf1 on deregu-
lated differentiation of Bmi1/Ink4a-Arf/ HSCs, we infected
Ink4a-Arf/ and Bmi1/Ink4a-Arf/ HSCs purified from
primary recipient mice with a lentivirus expressing shRNA
against Ebf1 and transplanted them into lethally irradiated recip-282 Cell Stem Cell 6, 279–286, March 5, 2010 ª2010 Elsevier Inc.ient mice. As expected, Ebf1 knockdown efficiently suppressed
B cell repopulation by both Ink4a-Arf/ and Bmi1/Ink4a-
Arf/ HSCs and significantly restored a drop in the KSL cell
fraction (HSCs/MPPs/LMPPs) repopulated by Bmi1/Ink4a-
Arf/ HSCs (Figure S3D). Unexpectedly, however, Ebf1 knock-
down profoundly affected the thymic T cell repopulation of both
Ink4a-Arf/ and Bmi1/Ink4a-Arf/ HSCs, probably because
of some adverse effects of the lentiviral knockdown system on
T cell repopulation (data not shown). These findings suggest
that premature expression of Ebf1 is one of the direct mecha-
nisms responsible for premature differentiation of Bmi1/
Ink4a-Arf/ HSCs/MPPs and their enhanced commitment to
B lineage lymphocytes.
Loss of Bmi1 Enhances Commitment of LMPPs
and CLPs and trans-Differentiation of CMPs
into the B Cell Lineage
To further evaluate the capacity for lineage commitment and
differentiation of Bmi1/Ink4a-Arf/multipotent stem/progen-
itor cells, we conducted lymphoid differentiation assays in vitro.
A
Wild-type
Ink4a-Arf
-/-
Bmi1
-/-
Bmi1
-/-
Ink4a-Arf
-/-
0 2 4 6 8 10 12 14
0
20
40
60
80
Days
C
el
l n
um
be
r (
x1
05
)
LMPP B
0
1
2
3
4
5
6
7
myeloid
pro-B
C
el
l n
um
be
r (
x1
05
)
Wild-type Ink4a-Arf-/- Bmi1
-/-
Ink4a-Arf
-/-
MPP C
0
1
2
3
4
5
6
7
C
el
l n
um
be
r (
x1
05
)
myeloid
pro-B
Wild-type Ink4a-Arf-/- Bmi1
-/-
Ink4a-Arf
-/-
LMPP
10
100
Input cells per well
%
 n
eg
at
iv
e 
w
el
ls
 (B
 c
el
l)
37
D
1/6 1/1171/89
LMPP on TSt-4
0 5 10 15 20 25 30
10
100
Input cells per well
%
 n
eg
at
iv
e 
w
el
ls
 (B
 c
el
l)
37
E
1/1.4 1/18 1/29
CLP on TSt-4
0 100 200 300 400
10
100
Input cells per well
%
 n
eg
at
iv
e 
w
el
ls
 (B
 c
el
l)
37
F
1/112
CMP on TSt-4
N.D.
N.D.
0 10 20 30 40 50 60
10
100
Input cells per well
%
 n
eg
at
iv
e 
w
el
ls
 (T
 c
el
l)
37
G
1/161/13
1/17
LMPP on TSt-4/DLL1
0 25 50 75 100 125 150
10
100
Input cells per well
%
 n
eg
at
iv
e 
w
el
ls
 (T
 c
el
l)
37
H
1/20 1/761/29
CLP on TSt-4/DLL1
0 20 40 60 80 100 120
10
100
Input cells per well
%
 n
eg
at
iv
e 
w
el
ls
 (B
 c
el
l)
37
I
1/37
LMPP on TSt-4/DLL1
N.D.
N.D.
0 50 100 150 200 250
10
100
Input cells per well
%
 n
eg
at
iv
e 
w
el
ls
 (B
 c
el
l)
37
J
1/11 1/240
1/240
CLP on TSt-4/DLL1
0 25 50 75 100 125 150
K
Ebf1
IL-7Ra
E2A
PU.1
Bmi1
Pax5
mb-1
CD19
l5
VpreB
Rag1
B29
Blk
?
B cell lineage differentiation
Wild-type Ink4a-Arf-/- Bmi1-/-Ink4a-Arf-/-
Figure 4. Enhanced Commitment of
Bmi1/Ink4a-Arf/ LMPPs and CLPs to
the B Cell Lineage In Vitro
(A) Growth of LMPPs from indicated 4-week-old
mutant mice. Freshly isolated cells were cultured
in the presence of SCF, Flt3L, and IL-7, and the
results are shown as the mean ± SD for triplicate
cultures.
(B andC) Numbers of CD43+B220+ pro-B cells and
Gr1+Mac1+ myeloid cells in culture. Freshly iso-
lated MPPs (B) and LMPPs (C) from wild-type
recipient BM repopulated by BM cells of indicated
mutant mice were cultured in the presence of SCF,
Flt3L, IL-7, and IL-3, and were counted and
analyzed by flow cytometry after 14 days of
culture. Data are shown as the mean ± SD for
triplicate cultures.
(D–F) Limiting dilution analyses of B cell develop-
ment from donor-derived LMPPs (D), CLPs (E),
and CMPs (F). Freshly isolated cells were cocul-
tured with TSt-4 stromal cells, and the generation
of B220+CD43+ pro-B cells in each well was de-
tected by flow cytometry after 14 days of cocul-
ture. The calculated frequencies are indicated
inside of the plot. Gray, wild-type; blue, Ink4a-
Arf/; green, Bmi1/Ink4a-Arf/. N.D., not
detected.
(G–J) Limiting dilution analyses of T cell develop-
ment from donor-derived LMPPs (G) and CLPs
(H). Freshly isolated cells were cocultured with
TSt-4/DLL1 stromal cells, and the generation of
CD4+CD8+ DP cells in each well was detected by
flow cytometry after 21 days of coculture.
B220+CD43+ pro-B cells were detected in the
same culture of LMPPs (I) and CLPs (J). The calcu-
lated frequencies are indicated inside of the
plot. Gray, wild-type; blue, Ink4a-Arf/; green,
Bmi1/Ink4a-Arf/.
(K) Transcriptional networks involved in B cell
specification and commitment. This study
unveiled that Bmi1 is a crucial negative regulator
of Ebf1 and Pax5 transcription. See also Figure S4.
Cell Stem Cell
Bmi1 Inhibits Premature Differentiation of HSCsWe first cultured LMPPs and CLPs under B cell-inducing condi-
tions. In contrast to the LMPPs from Bmi1/ mice, which re-
sponded little to IL-7, the LMPPs from Bmi1/Ink4a-Arf/
mice were hypersensitive to IL-7 and showed enhanced prolifer-
ation compared to those from wild-type and Ink4a-Arf/ mice
(Figure 4A). Comparable growth responses were observed with
LMPPs and CLPs purified from wild-type recipients repopulated
by Bmi1/Ink4a-Arf/ BM cells (Figures S4A and S4B). Under
conditions that allowed both myeloid and B cell differentiation,
Bmi1/Ink4a-Arf/MPPs and LMPPs exhibited almost normal
myeloid differentiation, but again generated B cells more inten-
sively (Figures 4B and 4C). To determine the probability of
Bmi1/Ink4a-Arf/ progenitors committing to the B cell
lineage, we next performed limiting dilution assays via a cocul-
ture system with TSt-4 stromal cells (Masuda et al., 2005). The
frequency of progenitors producing B cells was markedlyelevated, with Bmi1/Ink4a-Arf/ LMPPs and CLPs being
more than 10-fold higher than with wild-type and Ink4a-Arf/
cells (Figures 4D and 4E). This finding was also confirmed by
a single-cell analysis (Figure S4C). To our surprise, Bmi1/
Ink4a-Arf/ CMPs, in which Ebf1 and Pax5 expression was
ectopically derepressed, gave rise to B cells, although at a low
frequency (Figure 4F), suggesting that B cell potential is not
completely suppressed in CMPs. In contrast, Bmi1/Ink4a-
Arf/ LMPPs and CLPs showed T cell production at levels
comparable to those of wild-type and Ink4a-Arf/ mice under
T cell-inducing conditions that involved TSt-4/DLL1 stromal cells
expressing a Notch ligand, Delta-like 1 (DLL1) (Figures 4G and
4H; Masuda et al., 2005). Of interest, however, intensive B cell
production was observed with Bmi1/Ink4a-Arf/ LMPPs
and CLPs but not with wild-type or Ink4a-Arf/ cells under the
T cell conditions (Figures 4I and 4J). These results suggest thatCell Stem Cell 6, 279–286, March 5, 2010 ª2010 Elsevier Inc. 283
Cell Stem Cell
Bmi1 Inhibits Premature Differentiation of HSCsalthough Bmi1/Ink4a-Arf/ progenitors retain the potential to
generate T cells in vitro, their commitment status is highly
skewed to the B cell lineage in BM, where the Notch signal is
relatively weak, because of derepressed expression of Ebf1
and Pax5.
We next analyzed the capacity of Bmi1/Ink4a-Arf/ MPPs
and LMPPs to differentiate into the myeloid lineage. Colony
assays did not show any differences in the potential to differen-
tiate into neutrophils, macrophages, erythroblasts, and mega-
karyocytes but showed a slight reduction in numbers and colony
size (Figures S4D and S4E). A reduced proliferative capacity of
Bmi1/Ink4a-Arf/ cells was apparent in liquid cultures under
myeloid culture conditions (Figures S4F and S4G). Ectopic
expression of Ebf1 and Pax5 reportedly blocks myeloid differen-
tiation (Souabni et al., 2002; Pongubala et al., 2008). Thus, it is
possible that even under myeloid culture conditions, commit-
ment into B cells is enhanced by the ectopic expression of
Ebf1 and Pax5, resulting in reduced proliferation of myeloid
lineage cells.
DISCUSSION
In this study, we unexpectedly identified that loss of Bmi1 leads
to premature expression of B cell lineage developmental regu-
lator genes, Ebf1 and Pax5, and their downstream target genes
in HSCs/MPPs. In an Ink4a/Arf null genetic background (Bmi1/
Ink4a-Arf/), Bmi1-deficient HSCs that reacquired self-renewal
capacity showed accelerated lymphoid specification, resulting
in a drastic increase in CLPs at the expense of the HSC/MPP
pool size. In fact, HSCs, MPPs, and LMPPs were considerably
decreased in absolute numbers. These findings clearly indicate
that Bmi1 functions as a negative regulator of lymphoid specifi-
cation in HSCs/MPPs and, by postponing lineage specification,
contributes to the maintenance of their multipotent status
(Figure 4K; Figure S4H).
Ebf1 and Pax5 appeared to be transcriptionally repressed by
bivalent domains coregulated by both PRC1 and PRC2 before
lineage commitment. Bivalent domains in ESCs consist of
a repressive PRC2 mark, H3K27me3, and an active trxG mark,
H3K4me3. Recently, PRC1 was revealed to coregulate the vast
majority of developmental regulator gene promoters marked
with bivalent domains (Ku et al., 2008). Of note, the Ebf1 and
Pax5 promoters lost, to a significant extent, not only the PRC1
mark, H2Aub1, but also H3K27me3 in Bmi1/Ink4a-Arf/ Lin-
eage progenitors, while H3K4me3 levels were left unchanged
(Figure S2). Although the PRC1 mark, H2Aub1, reportedly
contributes to gene silencing by impeding RNA polymerase II
elongation, our findings indicate that Bmi1 is required tomaintain
the Ebf1 and Pax5 promoters in a bivalent state, thus suggesting
that PRC1 or its epigenetic mark, H2Aub1, collaborates with
PRC2 in the maintenance/stabilization of the H3K27me3 modifi-
cation at key developmental regulator gene loci.
Stem cells are defined as cells with self-renewal and multiline-
age differentiation capacity. Bmi1 maintains the self-renewal
capacity of HSCs by repressing the tumor suppressor genes
represented by Ink4a and Arf (Sparmann and van Lohuizen,
2006). The findings of this study demonstrate that Bmi1 keeps
differentiation programs poised for activation in HSCs/MPPs to
maintain their multipotency. Taken together with our previous284 Cell Stem Cell 6, 279–286, March 5, 2010 ª2010 Elsevier Inc.observation that forced expression of Bmi1 enhances the self-
renewal and multipotency of HSCs (Iwama et al., 2004), rein-
forcement of bivalent domains by Bmi1 at promoters of develop-
mental regulator genes and tumor suppressor genes might
enhance the stemness of HSCs. This might be true for cancer
stem cells. BMI1 expression is often upregulated in human
cancers, particularly in cancer stem cells (Sparmann and van
Lohuizen, 2006; Chiba et al., 2008). Higher levels of BMI1 could
enhance self-renewal capacity and keep developmental regu-
lator genes poised for activation, leading to an augmentation of
the tumorigenicity of cancer stem cells.
In this study, we also demonstrated that Bmi1 balances
B versus T cell lineage commitment of uncommitted lymphoid
progenitors by tuning the expression of Ebf1 and Pax5. Bmi1/
Ink4a-Arf/ lymphoid progenitors preferentially committed to
the B lymphoid lineage, but their T lineage commitment was
severely inhibited in BM because of derepressed Ebf1 and
Pax5 expression. Unexpectedly, Bmi1/Ink4a-Arf/ LMPP/
CLPs could produce T cells at a comparable level to controls
when cocultured with TSt-4/DLL1 stromal cells. However,
Bmi1/Ink4a-Arf/ LMPPs did not show any defects in migra-
tion/homing to and expansion in the thymus, suggesting that the
reduced production of T cell progenitors in BM accounts for the
impaired thymic reconstitution. It is possible that a strong Notch
signal from TSt-4/DLL1 cells overrode moderate levels of Ebf1
and Pax5 derepressed in Bmi1/Ink4a-Arf/ LMPPs. By
contrast, moderate levels of Ebf1 and Pax5 were enough to
overcome a weak Notch signal in BM and restrict commitment
of LMPPs to the B cell lineage. We further observed lineage
conversion of CMPs to the B lineage. All these findings suggest
that the PRC1 mark, H2Aub1, is required to maintain gene
silencing of Ebf1 and Pax5 not only in HSCs/MPPs but also in
myeloid progenitors (Figure S4H).
Our findings also provide important insight into how PcG-
mediated repression of developmental regulator genes is
released during normal differentiation. The IL-7 signal activates
Ebf1 transcription (Dias et al., 2008; Laslo et al., 2008) and
Bmi1 function is supposedly regulated by its phosphorylation
status (Voncken et al., 1999). Based on our findings that an
absence of Bmi1 triggers a resolution of bivalency at the Ebf1
and Pax5 promoters, it would be of importance to uncover the
crosstalk between the external signals, including IL-7 signal,
and Bmi1 function in terms of the epigenetic regulation of devel-
opmental regulator gene transcription (Figure 4K).
EXPERIMENTAL PROCEDURES
Mice
Bmi1+/mice and Ink4a-Arf/mice in aC57BL/6 (B6-Ly5.2) backgroundwere
used. C57BL/6 (B6-Ly5.2) mice were purchased from Japan SLC (Shizuoka,
Japan). C57BL/6 mice congenic for the Ly5 locus (B6-Ly5.1) were purchased
from Sankyo-Lab Service (Tsukuba, Japan). Mice were bred andmaintained in
the Animal Research Facility of the Graduate School of Medicine, Chiba
University in accordance with our institutional guidelines.
Flow Cytometric Analysis and Sorting
Antibodies used in flow cytometric experiments and cell surface protein
expression used to define hematopoietic cell types are listed in Supplemental
Experimental Procedures. Lineage marker antibodies for BM cells were Gr-1,
Mac-1,Ter119,B220,CD4,andCD8a. Those for thymocyteswereGr-1,Mac-1,
Ter119, B220, CD4, CD8a, CD3, TCRgd, CD11c, and NK1.1. Flow cytometric
Cell Stem Cell
Bmi1 Inhibits Premature Differentiation of HSCsexperiments were performed with FACSVantage SE, FACSAria II (BD Biosci-
ences), MoFlo (Beckman Coulter), and JSAN (Bay Bioscience).
Bone Marrow Transplantation
For analyses of the ability of mutant hematopoietic cells to differentiate in a
normal environment, 2 3 106 BM mononuclear cells from 4-week-old B6-
Ly5.2 mutant mice were transplanted into wild-type B6-Ly5.1 mice irradiated
with a dose of 9.5 Gy. The ability of the Bmi1/microenvironment to support
B lymphopoiesis was evaluated by transplanting 2 3 106 wild-type BM cells
(B6-Ly5.1) into 4-week-old wild-type and Bmi1/ mice (B6-ly5.2) irradiated
with a dose of 6.0 Gy.
Cell Culture
For growth assays, sorted cells were cultured for 14 days in the presence of
20 ng/ml stem cell factor (SCF), 20 ng/ml Flt3 ligand (Flt3L), and 20 ng/ml
IL-7, with or without 20 ng/ml IL-3 (Peprotech). For the detection of B cells,
sorted cells were cultured for 14 days with TSt-4 stromal cells (Masuda
et al., 2005) in 48-well plates. For the detection of T cells, sorted cells were
cultured for 21 days with TSt-4/DLL stromal cells (Masuda et al., 2005). The
frequencies of B and T cell commitment were determined by limiting dilution
assays and calculated with L-Calc software (StemCell Technologies). All
culture experiments were performed with RPMI 1640 medium supplemented
with 10% fetal calf serum, 2 mM L-glutamine, 100 U/ml penicillin, 100 mg/ml
streptomycin, 50 mM 2-b-mercaptoethanol (Sigma), 1 mM sodium pyruvate,
and 0.1 mM nonessential amino acid solution (GIBCO BRL).
Statistical Analysis
Statistical significance was analyzed with an unpaired t test.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures
and four figures and can be found with this article online at doi:10.1016/
j.stem.2010.01.005.
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